HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Sogo Selected Research

Interleukin-2 (IL2)

2/2024MHY1485 potentiates immunogenic cell death induction and anti-cancer immunity following irradiation.
1/2022Synergistic anti-tumor efficacy of a hollow mesoporous silica-based cancer vaccine and an immune checkpoint inhibitor at the local site.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Sogo Research Topics

Disease

19Neoplasms (Cancer)
04/2024 - 01/2013
7Infections
12/2017 - 01/2008
5Inflammation (Inflammations)
08/2021 - 04/2009
4Lewis Lung Carcinoma
02/2024 - 01/2013
4Osteomyelitis
11/2017 - 01/2008
2Neoplasm Metastasis (Metastasis)
01/2019 - 10/2017
2Bacterial Infections (Bacterial Infection)
04/2011 - 09/2008
1Wounds and Injuries (Trauma)
01/2022
1Hypersensitivity (Allergy)
08/2021
1Hepatocellular Carcinoma (Hepatoma)
10/2013
1Fever (Fevers)
10/2013
1Burns
05/2013
1Brain Infarction
03/2013
1Infarction (Infarctions)
03/2013
1Bone Resorption
06/2007

Drug/Important Bio-Agent (IBA)

11Silicon Dioxide (Silica)FDA LinkGeneric
04/2024 - 06/2013
6Immunologic Adjuvants (Immunologic Adjuvant)IBA
04/2024 - 06/2013
5Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2017 - 08/2008
4AntigensIBA
04/2024 - 07/2016
4Poly I-CIBA
08/2021 - 10/2017
4aluminum sulfate (alum)IBA
08/2021 - 07/2013
4Durapatite (Hydroxylapatite)IBA
11/2017 - 06/2007
4ApatitesIBA
07/2013 - 09/2008
3Gatifloxacin (Zymar)FDA Link
11/2017 - 01/2011
3tricalcium phosphateIBA
01/2016 - 01/2011
3calcium phosphateIBA
06/2014 - 05/2013
3NitrogenIBA
04/2014 - 01/2013
2OvalbuminIBA
04/2024 - 10/2017
24,6- dimorpholino- N- (4- nitrophenyl)- 1,3,5- triazin- 2- amineIBA
02/2024 - 09/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024 - 01/2022
2Interleukin-2 (IL2)IBA
02/2024 - 01/2022
2Pathogen-Associated Molecular Pattern MoleculesIBA
04/2014 - 07/2013
2Tuberculin (PPD)IBA
10/2013 - 06/2013
2ZincIBA
05/2013 - 04/2009
2Therapeutic UsesIBA
05/2013 - 06/2007
2TitaniumIBA
01/2012 - 08/2008
2Laminin (Merosin)IBA
04/2011 - 09/2008
2Anti-Bacterial Agents (Antibiotics)IBA
01/2011 - 01/2008
1VaccinesIBA
02/2024
1Interleukin-12 (IL 12)IBA
02/2024
1Biomarkers (Surrogate Marker)IBA
01/2022
1Cancer VaccinesIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Fluorouracil (Carac)FDA LinkGeneric
09/2021
1MTOR InhibitorsIBA
09/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1SodiumIBA
01/2019
1SaltsIBA
01/2019
1Alum CompoundsIBA
12/2017
1AluminumIBA
12/2017
1Aluminum Hydroxide (Algeldrate)FDA Link
01/2016
1Protons (Proton)IBA
10/2013
1Proteins (Proteins, Gene)FDA Link
06/2013
1SuspensionsIBA
05/2013
14-trifluoromethylsalicylic acid (HTB)IBA
01/2013
1Phosphates (Orthophosphate)IBA
01/2013
1N-(3,4,5-trichlorophenyl)succinimideIBA
01/2013
1SilicatesIBA
03/2010
1beta-tricalcium phosphateIBA
01/2008
1polycaprolactoneIBA
01/2008
1Bone SubstitutesIBA
06/2007
1CarbonatesIBA
06/2007
1FluoridesIBA
06/2007

Therapy/Procedure

14Immunotherapy
04/2024 - 01/2013
5Nanospheres
01/2018 - 01/2016
4Therapeutics
01/2022 - 03/2013
4Debridement
11/2017 - 01/2008
3Radiotherapy
02/2024 - 10/2013
1Bone Nails
06/2014
1Injections
10/2013
1Fracture Fixation
08/2008
1Bone Screws
08/2008